Cholangiocarcinoma

Latest News

March 2nd 2021

NDA Submitted to FDA for Ivosidenib for Previously Treated IDH1-Mutated Cholangiocarcinoma

A supplemental new drug application has been submitted to the FDA for ivosidenib tablets (Tibsovo) as a potential therapeutic option for patients with previously treated, IDH1-mutated cholangiocarcinoma.

January 29th 2021

Data Demonstrate Efficacy of Silmitasertib Plus Gemcitabine and Cisplatin Combination Treatment for Cholangiocarcinoma

By Alana Hippensteele, Lead Editor

January 19th 2021

Cholangiocarcinoma Therapy Trial Demonstrates Promising Results in Study

April 17th 2020

Pemigatinib Approved by FDA as First Targeted Treatment for Patients With Cholangiocarcinoma

By Jill Murphy, Assistant Editor

September 30th 2019

ClarIDHy Trial: First Targeted Therapy to Improve Outcomes in Cholangiocarcinoma

Cholangiocarcinoma

Latest News

Trending on Pharmacy Times

FDA Reportedly Shelves Commissioner's National Priority Voucher Program

Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines

Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention

Glucose Monitoring: Timing Makes Every Reading Count

Navigating State Vaccine Regulations: Challenges for Community Pharmacies